• About us
• Contact

Advertisement

Person › Details

Vered Caplan (Orgenesis Inc. (Nasdaq: ORGS))

Caplan, Vered (Orgenesis 201512 CEO)

 

	Organisation	Orgenesis Inc. (Nasdaq: ORGS)
	Group	Orgenesis (Group)
	Product	antidiabetic
	Product 2	cell therapy

Record changed: 2021-11-29

Advertisement

More documents for Vered Caplan

• [1] Orgenesis Inc.. (11/29/21). "Press Release: Orgenesis and Theracell Joint Venture to Receive up to €32 Million From Greek Government to Accelerate Rollout of POCare Centers and Deployment of OMPULs". Germantown, MD....
• [2] MaSTherCell Global, Inc.. (1/25/19). "Press Release: Great Point Partners-backed Strategic Partner MaSTherCell Global Announces Achievement of First Milestone Funding and Expansion with New Facility in Houston, Texas". Greenwich, CT & Houston, TX....
• [3] Orgenesis Inc.. (1/22/18). "Press Release: Orgenesis Announces a Strategic Corporate Regrouping of its CDMO Activities Under the Global MaSTherCell Brand & Service Offerings Alignment". Germantown, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.